Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies

Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies

Background: Inflammatory bowel diseases (IBDs) are generally not considered a risk factor for the development of lymphoma. When considering IBD treatments, there is good evidence supporting thiopurines (azathioprine, 6-mercaptopurine) as a risk factor for lymphoma. Conversely, the association betwee...

Full description

Bibliographic Details
Main Authors: Sara Ferraro, Luca Leonardi, Irma Convertino, Corrado Blandizzi, Marco Tuccori
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Pharmacology
Subjects:
anti-TNF
lymphoma
observational study
inflammatory bowel disease
Crohn's disease
ulcerative colitis
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00247/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00247/full

Similar Items